Monthly Archives: September 2024

Living with an immune-mediated condition can be a difficult journey with many different treatments. For instance, patients with rheumatoid arthritis may begin their treatment with medications such as methotrexate, leflunomide, sulfasalazine, or hydroxychloroquine, but eventually have their doctor suggest trying a more advanced treatment. These … Continue reading →

Cancer treatments have greatly evolved to offer better results with fewer adverse effects. A newer family, called Immune Checkpoint Inhibitors (ICPis), falls under this category. ICPis are a type of immunotherapy for various cancers such as multiple myeloma, non-small cell … Continue reading →